104 related articles for article (PubMed ID: 1421161)
1. Ras in signal transduction.
Satoh T; Kaziro Y
Semin Cancer Biol; 1992 Aug; 3(4):169-77. PubMed ID: 1421161
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
3. [Ras p21 and signal transduction].
Kishi K; Tanaka K; Takai Y
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1107-21. PubMed ID: 8512342
[TBL] [Abstract][Full Text] [Related]
4. Rho small G protein and cytoskeletal control.
Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
6. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
7. GTPase activating proteins.
Bollag G; McCormick F
Semin Cancer Biol; 1992 Aug; 3(4):199-208. PubMed ID: 1421164
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
9. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
10. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
11. The role of ras proteins in insulin signal transduction.
Maassen JA; Burgering BM; Medema RH; Osterop AP; van der Zon GC; Möller W; Bos JL
Horm Metab Res; 1992 May; 24(5):214-8. PubMed ID: 1398459
[TBL] [Abstract][Full Text] [Related]
12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
13. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
14. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
15. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
16. The role of p21ras in receptor tyrosine kinase signaling.
Medema RH; Bos JL
Crit Rev Oncog; 1993; 4(6):615-61. PubMed ID: 8286433
[TBL] [Abstract][Full Text] [Related]
17. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
Wisdom R; Huynh L; Hsia D; Kim S
Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
[TBL] [Abstract][Full Text] [Related]
18. Ha-ras in normal and tumoral tissues: structure, function and regulation.
Solanas M; Escrich E
Rev Esp Fisiol; 1996 Sep; 52(3):173-92. PubMed ID: 8974153
[TBL] [Abstract][Full Text] [Related]
19. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
20. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
